Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong M Shin

Showing results (11-20 of 253) with videos related to

Pageof 26
Sort By:
Expert Opinion on Emerging Drugs|May 25, 2004
Emerging drugs for head and neck cancerJohn C Rhee, Fadlo R Khuri, Dong M Shin
Acta Biochimica Et Biophysica Sinica|November 19, 2015
Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunitiesJun Zhang, Dongkyoo Park, Dong M Shin, et al.
The Oncologist|June 1, 2004
Advances in chemoprevention of head and neck cancerJohn C Rhee, Fadlo R Khuri, Dong M Shin
Nature Reviews. Drug Discovery|September 2, 2008
Nanoparticle therapeutics: an emerging treatment modality for cancerMark E Davis, Zhuo Georgia Chen, Dong M Shin
Oncology (Williston Park, N.Y.)|March 28, 2006
Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancerNabil F Saba, Fadlo R Khuri, Dong M Shin
Current Cancer Drug Targets|November 30, 2007
Targeting angiogenesis in head and neck cancerNabil F Saba, Dong M Shin, Fadlo R Khuri
Expert Review of Anticancer Therapy|June 25, 2003
Targeting epidermal growth factor receptor: novel therapeutics in the management of cancerMazen Y Khalil, Jennifer R Grandis, Dong M Shin
Molecular Cancer Therapeutics|August 25, 2006
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug deliveryRajni Sinha, Gloria J Kim, Shuming Nie, et al.
Cancer Research and Treatment|August 19, 2009
Advances of cancer therapy by nanotechnologyXu Wang, Yiqing Wang, Zhuo Georgia Chen, et al.
CA: a Cancer Journal for Clinicians|January 30, 2008
Application of nanotechnology in cancer therapy and imagingXu Wang, Lily Yang, Zhuo Georgia Chen, et al.
Pageof 26

Showing results (11-20 of 253) with videos related to

Sort By:
Pageof 26
Expert Opinion on Emerging Drugs|May 25, 2004
Emerging drugs for head and neck cancerJohn C Rhee, Fadlo R Khuri, Dong M Shin
Acta Biochimica Et Biophysica Sinica|November 19, 2015
Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunitiesJun Zhang, Dongkyoo Park, Dong M Shin, et al.
The Oncologist|June 1, 2004
Advances in chemoprevention of head and neck cancerJohn C Rhee, Fadlo R Khuri, Dong M Shin
Nature Reviews. Drug Discovery|September 2, 2008
Nanoparticle therapeutics: an emerging treatment modality for cancerMark E Davis, Zhuo Georgia Chen, Dong M Shin
Oncology (Williston Park, N.Y.)|March 28, 2006
Targeting the epidermal growth factor receptor. Trials in head and neck and lung cancerNabil F Saba, Fadlo R Khuri, Dong M Shin
Current Cancer Drug Targets|November 30, 2007
Targeting angiogenesis in head and neck cancerNabil F Saba, Dong M Shin, Fadlo R Khuri
Expert Review of Anticancer Therapy|June 25, 2003
Targeting epidermal growth factor receptor: novel therapeutics in the management of cancerMazen Y Khalil, Jennifer R Grandis, Dong M Shin
Molecular Cancer Therapeutics|August 25, 2006
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug deliveryRajni Sinha, Gloria J Kim, Shuming Nie, et al.
Cancer Research and Treatment|August 19, 2009
Advances of cancer therapy by nanotechnologyXu Wang, Yiqing Wang, Zhuo Georgia Chen, et al.
CA: a Cancer Journal for Clinicians|January 30, 2008
Application of nanotechnology in cancer therapy and imagingXu Wang, Lily Yang, Zhuo Georgia Chen, et al.
Pageof 26